A review of interleukin-2 receptor antagonists in solid organ transplantation.

Berard, J L; Velez, R L; Freeman, R B; Tsunoda, S M

Berard, J L; Velez, R L; Freeman, R B; Tsunoda, S M.

Affiliation

Berard JL; Department of Pharmacy Practice, School of Pharmacy, Bouvé College of Health Sciences, Northeastern University, Boston, Massachusetts 02115-5000, USA.

Pharmacotherapy ; 19(10): 1127-37, 1999 Oct.

Article in En | MEDLINE | ID: mdl-10512062

Subject(s)

Graft Rejection/prevention & control; Immunosuppressive Agents/pharmacology; Organ Transplantation/physiology; Receptors, Interleukin-2/antagonists & inhibitors; Recombinant Fusion Proteins; Adult; Antibodies, Monoclonal/administration & dosage; Antibodies, Monoclonal/adverse effects; Antibodies, Monoclonal/pharmacology; Antibodies, Monoclonal, Humanized; Basiliximab; Child, Preschool; Clinical Trials as Topic; Daclizumab; Humans; Immunoglobulin G/administration & dosage; Immunoglobulin G/adverse effects; Immunoglobulin G/pharmacology; Immunosuppressive Agents/administration & dosage; Immunosuppressive Agents/adverse effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Receptors, Interleukin-2 / Organ Transplantation / Graft Rejection / Immunosuppressive Agents Type of study: Prognostic_studies Limits: Adult / Child, preschool / Humans Language: En Journal: Pharmacotherapy Year: 1999 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links